XML 25 R13.htm IDEA: XBRL DOCUMENT
v3.21.2

EMPLOYEE BENEFIT PLANS | 6 Months Ended
--- | ---
Jul. 03, 2021
Share-based Payment Arrangement [Abstract] |
EMPLOYEE BENEFIT PLANS | EMPLOYEE BENEFIT PLANS Stock-Based Compensation Plans. The following table summarizes stock options and stock appreciation rights activity during the Second Quarter:
Stock Options and Stock Appreciation Rights |  | Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term |  | Aggregate Intrinsic Value
|  | (in Thousands) |  |  |  | (in Years) |  | (in Thousands)
Outstanding at April 3, 2021 |  | 286 |  |  | $ | 72.78 |  |  | 2.2 |  | $ | — |
Forfeited or expired |  | (3) |  |  | 95.91 |  |  |  |  |
Outstanding at July 3, 2021 |  | 283 |  |  | 72.58 |  |  | 2.0 |  | — |
Exercisable at July 3, 2021 |  | 283 |  |  | $ | 72.58 |  |  | 2.0 |  | $ | — |
The aggregate intrinsic value shown in the table above is based on the exercise price for outstanding and exercisable options/rights at July 3, 2021. Stock Options and Stock Appreciation Rights Outstanding and Exercisable. The following tables summarize information with respect to stock options and stock appreciation rights outstanding and exercisable at July 3, 2021:
Stock Options Outstanding |  | Stock Options Exercisable
Range of Exercise Prices |  | Number of Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term |  | Number of Shares |  | Weighted- Average Exercise Price
|  | (in Thousands) |  |  |  | (in Years) |  | (in Thousands) |  |
$101.37 - $131.46 |  | 58 |  |  | $ | 128.13 |  |  | 0.7 |  | 58 |  |  | $ | 128.13 |
Total |  | 58 |  |  | $ | 128.13 |  |  | 0.7 |  | 58 |  |  | $ | 128.13 |
Stock Appreciation Rights Outstanding |  | Stock Appreciation Rights Exercisable
Range of Exercise Prices |  | Number of Shares |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term |  | Number of Shares |  | Weighted- Average Exercise Price
|  | (in Thousands) |  |  |  | (in Years) |  | (in Thousands) |  |
$29.49 - $47.99 |  | 146 |  |  | $ | 40.92 |  |  | 2.8 |  | 146 |  |  | $ | 40.92 |
$55.04 - $82.55 |  | 48 |  |  | 77.43 |  |  | 1.8 |  | 48 |  |  | 77.43 |
$101.37 - $113.04 |  | 31 |  |  | 110.68 |  |  | 0.8 |  | 31 |  |  | 110.68 |
Total |  | 225 |  |  | $ | 58.28 |  |  | 2.3 |  | 225 |  |  | $ | 58.28 |
Restricted Stock Units and Performance Restricted Stock Units. The following table summarizes restricted stock unit and performance restricted stock unit activity during the Second Quarter:
Restricted Stock Units and Performance Restricted Stock Units |  | Number of Shares |  | Weighted-Average Grant Date Fair Value Per Share
|  | (in Thousands) |  |
Nonvested at April 3, 2021 |  | 1,635 |  |  | $ | 7.83 |
Granted |  | 947 |  |  | 13.23
Vested |  | (755) |  |  | $ | 9.90 |
Forfeited |  | (1) |  |  | 6.51
Nonvested at July 3, 2021 |  | 1,826 |  |  | $ | 9.78 |
The total fair value of restricted stock units vested during the Second Quarter was approximately $9.3 million. Vesting of performance restricted stock units is based on achievement of operating margin growth and achievement of sales growth and operating margin targets in relation to the performance of a certain identified peer group. Long-Term Incentive Plans. On the date of the Company’s annual stockholders meeting, each non-employee director automatically receives a grant of restricted stock units with a fair market value of approximately $130,000, which vest 100% on the earlier of one year from the date of grant or the date of the Company's next annual stockholders meeting, provided such director is providing services to the Company or a subsidiary of the Company on that date. Beginning with the grant in fiscal year 2021, non-employee directors may elect to defer receipt of all or a portion of the restricted stock units settled in common stock of the Company upon the vesting date. In addition, beginning in fiscal year 2021, non-employee directors may defer the cash portion of their annual fees. Each participant may also elect to have the cash portion of his or her annual fees for each calendar year treated as if invested in units of common stock of the Company.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration